O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura

Detalhes bibliográficos
Autor(a) principal: Brambilla, Talita Gomes [UNESP]
Data de Publicação: 2010
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/149426
http://www.athena.biblioteca.unesp.br/exlibris/bd/capelo/2017-01-26/000855204.pdf
Resumo: Oral anticoagulants (AOC) and antiplatelet drugs are used for prevention of thromboembolic events such as pulmonary thromboembolism in patients with atrial fribrilação and / or heart valves, thrombosis and pulmonary embolism, it is considered vitamin K antagonists. The most known and widely used, warfarin sodium that acts by inhibiting or antagonizing factors II, VII, IX and X coagulation, vitamin K-dependent, and the anticoagulant proteins C and S, and aspirin that inhibits platelet aggregation. For dental patients indicated surgical procedures were asked to discontinue the use of anticoagulants, until the INR value remained ≥ 2.0 that in order to prevent bleeding during the surgery and postoperative. However, the interruption of the AOC can cause the formation of a blood clot leading to obstruction of the blood. Thus, it was doubtful whether the discontinuation of the drug to perform minor surgery, in which local hemostatic measures would be sufficient to stop blood flow. Thus the main purpose was to assess the risk of bleeding in patients using local AOC who undergo surgical procedures, through a literature review of relevant clinical trials published between 1990 and 2010, the Medline / Pubmed. In this literature review concluded, based on evidence from studies reported that the benefit of preventing thromboembolism outweighs the risk of bleeding, therefore, it is recommended to keep the dose of anticoagulant therapy unchanged for patients undergoing minor oral surgery and Implant Dentistry, working with therapeutic INR levels, and adopt local hemostatic measures - such as the use of antifibrinolytic agents, gels, compresses. Moreover, an accurate surgical technique should be performed in these patients. With respect to oral surgery more invasive with a risk of bleeding may be a need for treatment in conjunction with a medical team
id UNSP_ebd34256aeedc1751917afa480c63f76
oai_identifier_str oai:repositorio.unesp.br:11449/149426
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literaturaCirurgia bucalAnticoagulantesHemostasiaSurgery, OralOral anticoagulants (AOC) and antiplatelet drugs are used for prevention of thromboembolic events such as pulmonary thromboembolism in patients with atrial fribrilação and / or heart valves, thrombosis and pulmonary embolism, it is considered vitamin K antagonists. The most known and widely used, warfarin sodium that acts by inhibiting or antagonizing factors II, VII, IX and X coagulation, vitamin K-dependent, and the anticoagulant proteins C and S, and aspirin that inhibits platelet aggregation. For dental patients indicated surgical procedures were asked to discontinue the use of anticoagulants, until the INR value remained ≥ 2.0 that in order to prevent bleeding during the surgery and postoperative. However, the interruption of the AOC can cause the formation of a blood clot leading to obstruction of the blood. Thus, it was doubtful whether the discontinuation of the drug to perform minor surgery, in which local hemostatic measures would be sufficient to stop blood flow. Thus the main purpose was to assess the risk of bleeding in patients using local AOC who undergo surgical procedures, through a literature review of relevant clinical trials published between 1990 and 2010, the Medline / Pubmed. In this literature review concluded, based on evidence from studies reported that the benefit of preventing thromboembolism outweighs the risk of bleeding, therefore, it is recommended to keep the dose of anticoagulant therapy unchanged for patients undergoing minor oral surgery and Implant Dentistry, working with therapeutic INR levels, and adopt local hemostatic measures - such as the use of antifibrinolytic agents, gels, compresses. Moreover, an accurate surgical technique should be performed in these patients. With respect to oral surgery more invasive with a risk of bleeding may be a need for treatment in conjunction with a medical teamOs anticoagulantes orais (AOC) e antiagregantes plaquetários são drogas utilizadas para a prevenção de fenômenos tromboembólicos, como tromboembolismo pulmonar em pacientes com fribrilação atrial e/ou válvulas cardíacas, trombose e embolismo pulmonar, sendo considerados antagonistas da vitamina K. Os mais conhecidos e amplamente utilizados, a varfarina sódica que age inibindo ou antagonizando os fatores II, VII, IX e X da coagulação, dependentes da vitamina K e, das proteínas anticoagulantes C e S e, a aspirina que inibe a agregação plaquetária. Para pacientes odontológicos indicados a realização de procedimentos cirúrgicos eram solicitados a interromperem o uso dos anticoagulantes, até que o valor do INR se mantivesse ≥ que 2.0, de modo a evitar hemorragias no trans e pós-operatório. No entanto, a interrupção do AOC pode causar a formação de um coágulo sanguíneo, levando a obstrução das vias sanguíneas. Sendo assim, tornava-se duvidoso a interrupção do medicamento para a realização de cirurgias de pequeno porte, em que medidas hemostáticas locais seriam suficientes para interromper o fluxo sanguíneo. Deste modo, o objetivo da revisão foi avaliar o risco de hemorragia local em pacientes usuários de AOC que são submetidos à procedimentos cirúrgicos, por meio de um levantamento bibliográfico realizado em estudos clínicos relevantes publicados entre 1990 e 2010, pela base Medline/Pubmed. Nesta revisão de literatura concluiu - se, com base na evidência dos estudos relatados, que o benefício da prevenção de tromboembolismo supera o risco de hemorragia, assim sendo, recomenda-se manter a dose da terapia com anticoagulantes inalterada para pacientes submetidos à cirurgia oral menor e Implantodontia, trabalhando com níveis de INR terapêutico, e adotar medidas hemostáticas locais - como o de uso de antifibrinolíticos, gel, compressas. Além...Universidade Estadual Paulista (Unesp)Ponzoni, Daniela [UNESP]Aranega, Alessandra Marcondes [UNESP]Universidade Estadual Paulista (Unesp)Brambilla, Talita Gomes [UNESP]2017-03-14T14:46:36Z2017-03-14T14:46:36Z2010-09-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesis44 f.application/pdfBRAMBILLA, Talita Gomes. O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura. 2010. 44 f. Trabalho de conclusão de curso (bacharelado - Odontologia) - Universidade Estadual Paulista Julio de Mesquita Filho, Faculdade de Odontologia de Araçatuba, 2010.http://hdl.handle.net/11449/149426000855204http://www.athena.biblioteca.unesp.br/exlibris/bd/capelo/2017-01-26/000855204.pdf6636749858940359Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2023-10-10T06:08:49Zoai:repositorio.unesp.br:11449/149426Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T14:33:42.144008Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
title O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
spellingShingle O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
Brambilla, Talita Gomes [UNESP]
Cirurgia bucal
Anticoagulantes
Hemostasia
Surgery, Oral
title_short O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
title_full O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
title_fullStr O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
title_full_unstemmed O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
title_sort O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura
author Brambilla, Talita Gomes [UNESP]
author_facet Brambilla, Talita Gomes [UNESP]
author_role author
dc.contributor.none.fl_str_mv Ponzoni, Daniela [UNESP]
Aranega, Alessandra Marcondes [UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Brambilla, Talita Gomes [UNESP]
dc.subject.por.fl_str_mv Cirurgia bucal
Anticoagulantes
Hemostasia
Surgery, Oral
topic Cirurgia bucal
Anticoagulantes
Hemostasia
Surgery, Oral
description Oral anticoagulants (AOC) and antiplatelet drugs are used for prevention of thromboembolic events such as pulmonary thromboembolism in patients with atrial fribrilação and / or heart valves, thrombosis and pulmonary embolism, it is considered vitamin K antagonists. The most known and widely used, warfarin sodium that acts by inhibiting or antagonizing factors II, VII, IX and X coagulation, vitamin K-dependent, and the anticoagulant proteins C and S, and aspirin that inhibits platelet aggregation. For dental patients indicated surgical procedures were asked to discontinue the use of anticoagulants, until the INR value remained ≥ 2.0 that in order to prevent bleeding during the surgery and postoperative. However, the interruption of the AOC can cause the formation of a blood clot leading to obstruction of the blood. Thus, it was doubtful whether the discontinuation of the drug to perform minor surgery, in which local hemostatic measures would be sufficient to stop blood flow. Thus the main purpose was to assess the risk of bleeding in patients using local AOC who undergo surgical procedures, through a literature review of relevant clinical trials published between 1990 and 2010, the Medline / Pubmed. In this literature review concluded, based on evidence from studies reported that the benefit of preventing thromboembolism outweighs the risk of bleeding, therefore, it is recommended to keep the dose of anticoagulant therapy unchanged for patients undergoing minor oral surgery and Implant Dentistry, working with therapeutic INR levels, and adopt local hemostatic measures - such as the use of antifibrinolytic agents, gels, compresses. Moreover, an accurate surgical technique should be performed in these patients. With respect to oral surgery more invasive with a risk of bleeding may be a need for treatment in conjunction with a medical team
publishDate 2010
dc.date.none.fl_str_mv 2010-09-29
2017-03-14T14:46:36Z
2017-03-14T14:46:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv BRAMBILLA, Talita Gomes. O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura. 2010. 44 f. Trabalho de conclusão de curso (bacharelado - Odontologia) - Universidade Estadual Paulista Julio de Mesquita Filho, Faculdade de Odontologia de Araçatuba, 2010.
http://hdl.handle.net/11449/149426
000855204
http://www.athena.biblioteca.unesp.br/exlibris/bd/capelo/2017-01-26/000855204.pdf
6636749858940359
identifier_str_mv BRAMBILLA, Talita Gomes. O uso de drogas anticoagulantes e antiplaquetárias orais em pacientes cirúrgico-ambulatoriais: revisão de literatura. 2010. 44 f. Trabalho de conclusão de curso (bacharelado - Odontologia) - Universidade Estadual Paulista Julio de Mesquita Filho, Faculdade de Odontologia de Araçatuba, 2010.
000855204
6636749858940359
url http://hdl.handle.net/11449/149426
http://www.athena.biblioteca.unesp.br/exlibris/bd/capelo/2017-01-26/000855204.pdf
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 44 f.
application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv Aleph
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128378383892480